We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna Starts Dosing Participants With COVID-19 Variant Booster
Moderna Starts Dosing Participants With COVID-19 Variant Booster
Moderna has announced that it has begun dosing trial participants with a modified COVID-19 vaccine meant to target the variant SARS-Cov-2 strain first identified in South Africa.